MedWatch

ALK CEO misses bonus target for fifth year in a row

CEO at ALK Carsten Hellmann has not unlocked the 2021 bonus tied to US success, as the company failed to meet its targets on the market.

Photo: Gregers Tycho/ERH

For allergy company ALK, the US is the promised land, and the company has been trying to establish itself there for several years.

Despite progress in 2021, it was still not CEO Carsten Hellmann’s year. The failure to crack the US market hits him where it hurts, as the payout of part of his bonus is tied to success on the market, Danish financial daily Børsen reports.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs